SEARCH

SEARCH BY CITATION

References

  • 1
    Engdahl J, Holmberg M, Karlson BW, Luepker R, Herlitz J. The epidemiology of out-of-hospital ‘sudden’ cardiac arrest. Resuscitation 2002;52:23545.
  • 2
    Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:55763.
  • 3
    Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:54956.
  • 4
    Holzer M, Bernard SA, Hachimi-Idrissi S, Roine RO, Sterz F, Mullner M. Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis. Crit Care Med 2005;33:4148.
  • 5
    Nolan JP, Morley PT, Vanden Hoek TL et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 2003;108:11821.
  • 6
    Fairchild KD, Singh IS, Patel S et al. Hypothermia prolongs activation of NF-kappaB and augments generation of inflammatory cytokines. Am J Physiol Cell Physiol 2004;287:C42231.
  • 7
    Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181:17680.
  • 8
    Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:55673.
  • 9
    Muller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007;30 (Suppl. 1):S1623.
  • 10
    Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177:498505.
  • 11
    Christ-Crain M, Stolz D, Bingisser R et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:8493.
  • 12
    Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:6007.
  • 13
    Schuetz P, Christ-Crain M, Wolbers M et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007;7:102.
  • 14
    Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype? Swiss Med Wkly 2009;139:31826.
  • 15
    Schuetz P, Christ-Crain M, Wolbers M et al. Effect of procalcitonin-based guidelines compared to standard guidelines on antibiotic use in lower respiratory tract infections: the Randomized-Controlled Multicenter ProHOSP Trial. JAMA 2009;302:105966.
  • 16
    Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010 [Epub ahead of print].
  • 17
    Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Bürgi U, Maurer M et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis 2009 [Epub ahead of print].
  • 18
    Christ-Crain M, Muller B. Procalcitonin in bacterial infections -- hype, hope, more or less? Swiss Med Wkly 2005;135:45160.
  • 19
    Franke A, Lante W, Kupser S, Becker HP, Weinhold C, Markewitz A. Procalcitonin levels after different types of conventional thoracic surgery. Thorac Cardiovasc Surg 2008;56:4650.
  • 20
    Hunziker S, Hügle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B et al . The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 2010;92:13848.
  • 21
    Buratti T, Ricevuti G, Pechlaner C et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 2001;25:97100.
  • 22
    Los Arcos M, Rey C, Concha A, Medina A, Prieto B. Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome. BMC Pediatr 2008;8:18.
  • 23
    Adib-Conquy M, Monchi M, Goulenok C et al. Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 2007;28:40610.
  • 24
    Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R. Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation 2003;59:1059.
  • 25
    Fries M, Stoppe C, Brucken D, Rossaint R, Kuhlen R. Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest. J Crit Care 2009;24:4537.
  • 26
    Mongardon N, Lemiale V, Perbet S et al. Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients. Intensive Care Med 2010;36:929.